Ontology-Guided Pathway Activity Identifies a Cell-Intrinsic Defense Response Program Associated with MEK Inhibitor Sensitivity
Abstract
Predicting cancer drug response from gene expression requires models that expose which biological pathways drive cell-line-specific sensitivity. We introduce Gene-Ontology Pathway Attention (GOPA), whose core module computes deterministic attention weights softmax(xc {middle dot}[B] ) from expression and the column-normalized gene-term annotation matrix with no learned parameters. Applying GOPA to 542 drugs across the GDSC panel under leave-cell-line-out evaluation, we find that defense response pathways predict sensitivity to kinase inhibitors in GDSC, with the strongest and most confound-resistant signal in MEK/MAPK inhibitors. This association shows cross-assay support in PRISM (11 of 11 overlapping drugs; all p < 0.002) and retains 72% signal strength after controlling for five confounds, but was not reproduced in the gCSI panel (different response metric, smaller sample, MEK inhibitors absent), indicating the finding may be MAPK-pathway-specific and assay-dependent. On the 16-drug benchmark, XGBoost achieves the lowest RMSE (1.185); GOPA (1.226) is the strongest neural model. On the full 542-drug panel, target-encoded XGBoost matches GOPA on RMSE (1.322 vs. 1.327); GOPA achieves higher residual Pearson correlation (0.469; 95% CI [0.453, 0.485]) than target-encoded XGBoost (0.391; [0.379, 0.404]); paired difference +0.078 [0.062, 0.093]; GOPA wins on 363 of 539 drugs (67.3%); Wilcoxon p = 1.1 x 10-23). When pathway representations are evaluated with matched downstream learners, simple gene-set projections achieve equivalent prediction, indicating that GOPAs value lies in its deterministic, population-comparable pathway summaries rather than representational superiority. A controlled geometry comparison shows Poincare-ball embeddings preserve GO graph distances better than Euclidean ({rho} = 0.732 vs. 0.474) while Euclidean embeddings achieve stronger ancestor retrieval; neither geometry improves prediction ({Delta}RMSE = +0.008; p = 0.18).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PathDSP: Explainable Drug Sensitivity Prediction through Cancer Pathway Enrichment
Yi-Ching Tang, Assaf Gottlieb·Scientific ReportsPeer-reviewed·Feb 4, 2021
- Dr.Paso: Drug response prediction and analysis system for oncology research
Francisco J Azuaje, Tony Kaoma, … Simone P. Niclou·bioRxiv·Dec 21, 2017
- Feature selection strategies for drug sensitivity prediction
Krzysztof Koras, Dilafruz Juraeva, … Ewa Szczurek·Scientific ReportsPeer-reviewed·Jun 10, 2020
- Pathway-guided deep neural network toward interpretable and predictive modeling of drug sensitivity
Lei Deng, Yideng Cai, … Hui Liu·Journal of Chemical Information and ModelingPeer-reviewed·Aug 17, 2020
- Gene expression based inference of drug resistance in cancer
S. Chawla, A. Rockstroh, … D. Sengupta·bioRxiv·Nov 17, 2021
- Pathway-extended gene expression signatures integrate novel biomarkers that improve predictions of patient responses to kinase inhibitors
A. J. Bagchee-Clark, E. J. Mucaki, … P. K. Rogan·bioRxiv·Nov 13, 2020